Predicting outcomes from coronary OCT images with AI
Official title: Optical Coherence Tomography: Prognostic Value and Artificial Intelligence
Run by Radboud University Medical Center · NCT07293858 · Data updated 2026-11-12
This project will try to see if details from coronary OCT scans and an AI tool can predict long-term outcomes in people with coronary artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 1 site (Nijmegen, Gelderland) |
| Status | Recruiting |
| Started | November 26, 2021 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | December 19, 2025 |
| Trial ID | NCT07293858 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with coronary artery disease who undergo intracoronary OCT during routine catheterization at Radboud University Medical Center or a participating site and can provide written informed consent.
✕Probably not a fit
Patients who do not undergo OCT, cannot provide informed consent, or cannot be followed (for example lacking valid contact details) are unlikely to benefit from this registry's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective registry enrolls consecutive patients who undergo intracoronary optical coherence tomography (OCT) as part of routine cardiac catheterization at Radboudumc and participating centers. High-resolution OCT pullbacks and clinical data are collected, and patients are followed for up to 10 years using medical records, questionnaires, and national registries to capture symptoms, medications, hospitalizations, procedures, and major cardiac events. The study will test whether OCT-derived plaque morphology, vulnerable features, or indicators of stent optimization are associated with long-term clinical outcomes. Pseudonymized OCT images will also be used to develop and train an AI algorithm for automated OCT annotation.
Why it matters
Potential benefit: If successful, this work could help clinicians better predict individual risk after coronary imaging and speed up OCT interpretation with AI, potentially informing treatment decisions.
How similar studies have gone: Previous studies have linked certain OCT features to adverse outcomes and early AI tools for OCT annotation have shown promise, but large-scale, long-term validation is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All consecutive patients undergoing intracoronary OCT imaging at the Radboud University Medical Center, and any additional centers that may join the study in the future. * OCT performed at the discretion of the treating physician, according to contemporary clinical guidelines. * Written informed consent obtained after the procedure. Exclusion Criteria: * Patients who decline or are unable to provide informed consent. (Only patients who provide consent can be included. * Patients for whom follow-up or data collection is not feasible (e.g., no valid contact details).
Where it's running
-
Radboudumc
Nijmegen, Gelderland, Netherlands Recruiting
Study contacts
- Study coordinator: Joske L. van der Zande
- Email: joske.vanderzande@radboudumc.nl
- Phone: 0622997212
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dual antihypertensive combinations after PCI: ARB + thiazide versus ARB + amlodipine
This trial tests two blood pressure treatment combos after a stent procedure in people with hypertension and coronary disease to see which regimen better controls blood pressure and improves symptoms.
-
Dapagliflozin and heart-pump fit after off-pump bypass
This study tests whether 10 mg/day of dapagliflozin helps the right heart work better with the lungs after OPCAB in adults with reduced heart pumping function.
-
ShockFast IVL vs ShockWave IVL for Calcified Coronary Lesions
This study tests whether the ShockFast intravascular lithotripsy device can perform as well as the established ShockWave IVL for treating calcified coronary lesions in adults undergoing PCI.
-
Erector spinae versus serratus posterior superior intercostal plane nerve blocks for pain after coronary bypass
This study will test whether an erector spinae plane block or a serratus posterior superior intercostal plane block provides better pain relief and reduces opioid use after elective coronary artery bypass graft surgery in adults aged 45–85.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.